3 Promising Penny Stocks With Market Caps Under US$300M [Yahoo! Finance]
Innate Pharma S.A. - American Depositary Shares (IPHA)
Company Research
Source: Yahoo! Finance
Amidst this backdrop, penny stocks remain an intriguing option for those looking to explore smaller or less-established companies that may offer value and growth potential. Despite being considered an outdated term by some, penny stocks highlight opportunities in firms with strong financials and the potential for significant returns. In this article, we spotlight three such stocks that stand out due to their robust balance sheets and promising prospects. Name Share Price Market Cap Financial Health Rating DXN Holdings Bhd (KLSE:DXN) MYR0.50 MYR2.49B ?????? Embark Early Education (ASX:EVO) A$0.78 A$143.12M ?????? Datasonic Group Berhad (KLSE:DSONIC) MYR0.43 MYR1.2B ?????? Hil Industries Berhad (KLSE:HIL) MYR0.885 MYR293.77M ?????? ME Group International (LSE:MEGP) £2.155 £811.93M ?????? Bosideng International Holdings (SEHK:3998) HK$3.92 HK$43.17B ?????? LaserBond (ASX:LBL) A$0.555 A$65.06M ?????? Begbies Traynor Group (
Show less
Read more
Impact Snapshot
Event Time:
IPHA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPHA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPHA alerts
High impacting Innate Pharma S.A. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IPHA
News
- Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Innate Pharma S.A. (NASDAQ: IPHA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.50 price target on the stock.MarketBeat
- Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell LymphomaBusiness Wire
- Innate Pharma and the Institute for Follicular Lymphoma Innovation (IFLI) Announce up to $7.9M Investment From IFLI to Support IPH6501 Development in Follicular LymphomaBusiness Wire